HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. 2003

Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, 615 North Wolfe Street (E-6008), Baltimore, MD 21205, U.S.A.

The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3%: 30.0% among 513 injection drug users (IDUs) and 2.8% among non-IDUs (OR = 14.8, 95% CI: 10.2, 21.6). HIV seroprevalence was 2.4% among exclusive methamphetamine users (98% of whom are non-IDUs) and 3.4% among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.

UI MeSH Term Description Entries
D008297 Male Males
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D003710 Demography Statistical interpretation and description of a population with reference to distribution, composition, or structure. Demographer,Demographic,Demographic and Health Survey,Population Distribution,Accounting, Demographic,Analyses, Demographic,Analyses, Multiregional,Analysis, Period,Brass Technic,Brass Technique,Demographers,Demographic Accounting,Demographic Analysis,Demographic Factor,Demographic Factors,Demographic Impact,Demographic Impacts,Demographic Survey,Demographic Surveys,Demographic and Health Surveys,Demographics,Demography, Historical,Demography, Prehistoric,Factor, Demographic,Factors, Demographic,Family Reconstitution,Historical Demography,Impact, Demographic,Impacts, Demographic,Multiregional Analysis,Period Analysis,Population Spatial Distribution,Prehistoric Demography,Reverse Survival Method,Stable Population Method,Survey, Demographic,Surveys, Demographic,Analyses, Period,Analysis, Demographic,Analysis, Multiregional,Demographic Analyses,Demographies, Historical,Demographies, Prehistoric,Distribution, Population,Distribution, Population Spatial,Distributions, Population,Distributions, Population Spatial,Family Reconstitutions,Historical Demographies,Method, Reverse Survival,Method, Stable Population,Methods, Reverse Survival,Methods, Stable Population,Multiregional Analyses,Period Analyses,Population Distributions,Population Methods, Stable,Population Spatial Distributions,Prehistoric Demographies,Reconstitution, Family,Reconstitutions, Family,Reverse Survival Methods,Spatial Distribution, Population,Spatial Distributions, Population,Stable Population Methods,Technic, Brass,Technique, Brass
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
January 2005, AIDS care,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
December 2010, Journal of acquired immune deficiency syndromes (1999),
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
December 2003, Journal of urban health : bulletin of the New York Academy of Medicine,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
October 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
March 2010, AIDS patient care and STDs,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
January 2006, Substance use & misuse,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
May 2005, Drug and alcohol dependence,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
September 2005, Journal of urban health : bulletin of the New York Academy of Medicine,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
August 2000, Epidemiology and infection,
Myat Htoo Razak, and Jaroon Jittiwutikarn, and Vinai Suriyanon, and Tassanai Vongchak, and Namtip Srirak, and Chris Beyrer, and Surinda Kawichai, and Sodsai Tovanabutra, and Kittipong Rungruengthanakit, and Pathom Sawanpanyalert, and David D Celentano
December 2010, Journal of addiction medicine,
Copied contents to your clipboard!